HAVA
NASDAQ · N/A
Harvard Ave Acquisition-Cl A
$10.09
+0.02 (+0.20%)
Open$10.09
Previous Close$10.07
Day High$10.09
Day Low$10.08
52W High$10.07
52W Low$9.87
Volume—
Avg Volume11.6K
Market Cap208.38M
P/E Ratio110.34
EPS$0.10
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 219.03M | 196.60M | 211.78M |
| Net Income | 8.69M | 7.47M | 7.70M |
| Profit Margin | 4.0% | 3.8% | 3.6% |
| EBITDA | 14.09M | 11.42M | 12.03M |
| Free Cash Flow | 7.43M | 6.90M | 7.76M |
| Rev Growth | +5.0% | -0.4% | +4.7% |
| Debt/Equity | 0.54 | 0.45 | 0.54 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $7.00 | -5.28% | — | 5.22B |
| PICS | Pics Nv | $10.89 | +0.83% | — | 1.50B |
| DMII | Drugs Made In America Acquis | $10.04 | +0.10% | 152.6 | 638.91M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.84B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.58 | +0.09% | 62.2 | 606.86M |
| CEPF | Cantor Equity Partners-Cl A | $10.29 | -0.10% | 96.1 | 589.22M |